# Intralesional Steroids in the Treatment of Alopecia Areata

> **NCT01898806** · PHASE4 · TERMINATED · sponsor: **Columbia University** · enrollment: 11 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Intralesional Triamcinolone 2.5 mg/ml
- **DRUG:** Intralesional Triamcinolone 5 mg/ml
- **DRUG:** Intralesional Triamcinolone 10 mg/ml
- **DRUG:** Intralesional Saline

## Key facts

- **NCT ID:** NCT01898806
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** The PI left the Columbia University Medical Center. Study was not Completed.
- **Last updated:** 2019-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898806, "Intralesional Steroids in the Treatment of Alopecia Areata". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01898806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*